Clinical Trial Update: Glucophage XR® Observational Study

View source ↗

Summary

An observational study of Glucophage XR (metformin extended-release) in type 2 diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage XR (metformin hydrochloride extended-release)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Diabetes Mellitus Type 2, GI Side Effect | Status: TERMINATED